Senior insider sale
EVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$27.48M
58.61K shares
What this filing means
SACHDEV AMIT plans to sell 58.61K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $27.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/19/2026ACC: 0001959173-26-001243
Officer· EVP, CRO
Since Jun 2018
58.61K
Shares to sell
$27.48M
Approx. market value
58.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Option Granted - 02/06/2019
Cash
2/19/2026
25.03KOption Granted - 02/06/2018
Cash
2/19/2026
23.48KRestricted Stock Vesting
Compensation
2/17/2026
2.60KRestricted Stock Vesting
Compensation
2/13/2026
4.32KRestricted Stock Vesting
Compensation
2/10/2026
3.19KTotal acquired58.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/19/2026 | Option Granted - 02/06/2019 Cash | 25.03K | — |
2/19/2026 | Option Granted - 02/06/2018 Cash | 23.48K | — |
2/17/2026 | Restricted Stock Vesting Compensation | 2.60K | — |
2/13/2026 | Restricted Stock Vesting Compensation | 4.32K | — |
2/10/2026 | Restricted Stock Vesting Compensation | 3.19K | — |
| Total | 58.61K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
58.61K
Market value
$27.48M
2/19/2026
Total
Units
58.61K
Value
$27.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/19/2026 | 58.61K | $27.48M | NASDAQ | Planned |
| Total | 58.61K | $27.48M | ||